Jobless Claims Remain Near Historic Lows Pointing to Continued Labor Market Resilience Strategy Pauses Bitcoin Accumulation to Prioritize 15B Bond Repurchase US Stock Futures Bond Yields Decline as Putin Revises Nuclear Doctrine UK Heatwave Drives Bank Holiday Travel Disruptions Potentially Impacting Retail and Transport Sectors ADP Report Shows Private Payrolls Rose by 109000 in April Exceeding Estimates US and Iran Nearing 60Day Ceasefire Extension with Strait of Hormuz Reopening Terms Parsons Corporation PSN Q1 2026 Earnings EPS Surges Past Estimates as Operational Execution Drives Performance AMT Q1 2026 Earnings EPS Surges Past Estimates with 1363 Beat SNOW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Gains Momentum INOD Q1 2026 Earnings Massive EPS Beat Drives Investor Skepticism EZRA Q1 2023 Earnings Massive EPS Surprise of 324 Against Negative Estimate Revenue Unreported Blackstone Secured Lending Fund BXSL Q1 2026 Earnings EPS Beat Driven by Strong Investment Income and Portfolio Performance XCHG Limited XCH Rebounds From Key Support Resistance Test Ahead Blackrock MuniYield Quality Fund III Inc MYI Rallies 15 as YieldSeekers Return Functional Brands Inc MEHA Slides 75 as Penny Stock Continues to Test Lower Support Twist Bioscience TWST Holds Steady Near Midpoint as Key Levels Define Trading Range CO2 Energy Transition Corp NOEM Holds Steady Near Trust Value as Support and Resistance Levels Defined OPLN Q1 2026 Earnings EPS Beats Estimates by 124 Stock Rises ICON Q4 2025 Earnings EPS Misses Estimates as Loss Widens Shares Rise 075 Value Line Inc Q1 2026 Earnings EPS of 069 Surprises Despite Revenue Silence 60 Degrees Pharmaceuticals Inc SXTP Q1 2026 Earnings EPS Misses Estimates No Revenue Yet Dine Brands Global Inc DIN Q1 2026 Earnings Earnings Per Share Beat Estimates Amidst Operational Focus Standard BioTools Q1 2026 Earnings Massive EPS Beat Fails to Lift Shares Amid Revenue Uncertainty Trump Pressures Bank of America JPMorgan Over Alleged AntiConservative Practices NCDL Q1 2026 Earnings EPS Miss Expected Stock Slips Phio Pharmaceuticals Holds Steady Near Support Levels PHIO Stock Consolidates in Narrow Range